Covid-19 Impact on Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2020-2026

July 2020 | 95 pages | ID: CF28AA2F149FEN
QYResearch

Abstracts

This report focuses on the global Pre-Implantation Genetic Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Implantation Genetic Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Roche
• Genea Limited
• Quest Diagnostics
• Illumina, Inc.
• Natera, Inc.
• Cooper Medical, Inc.
• LabCorp
• California Pacific Medical Center (CPMC)
• Thermo Fisher Scientific Inc.
• IGENOMIX
• Reproductive Genetic Innovations
• CombiMatrix

Market segment by Type, the product can be split into

• Chromosomal Abnormalities
• X-linked Diseases
• Freeze Embryo Testing
• Aneuploidy Screening
• HLA
• Others

Market segment by Application, split into

• Stem Cell Therapy
• IVF Prognosis
• Late-Onset Genetic Disorders
• Inherited Genetic Disease
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pre-Implantation Genetic Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players.
• To present the Pre-Implantation Genetic Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pre-Implantation Genetic Diagnosis (PGD) are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chromosomal Abnormalities
  1.4.3 X-linked Diseases
  1.4.4 Freeze Embryo Testing
  1.4.5 Aneuploidy Screening
  1.4.6 HLA
  1.4.7 Others
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026
  1.5.2 Stem Cell Therapy
  1.5.3 IVF Prognosis
  1.5.4 Late-Onset Genetic Disorders
  1.5.5 Inherited Genetic Disease
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pre-Implantation Genetic Diagnosis (PGD) Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pre-Implantation Genetic Diagnosis (PGD) Industry
    1.6.1.1 Pre-Implantation Genetic Diagnosis (PGD) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pre-Implantation Genetic Diagnosis (PGD) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pre-Implantation Genetic Diagnosis (PGD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions
  2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2015-2020)
  2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pre-Implantation Genetic Diagnosis (PGD) Market Growth Strategy
  2.3.6 Primary Interviews with Key Pre-Implantation Genetic Diagnosis (PGD) Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Market Size
  3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2015-2020)
  3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
  3.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2019
3.3 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.4 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
3.5 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2015-2020)
4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)
5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
6.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in North America (2019-2020)
6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
7.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Europe (2019-2020)
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

8 CHINA

8.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
8.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in China (2019-2020)
8.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
8.4 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
9.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Japan (2019-2020)
9.3 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
9.4 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
10.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
10.4 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

11 INDIA

11.1 India Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
11.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in India (2019-2020)
11.3 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
11.4 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020)
12.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020)
12.4 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Genea Limited
  13.2.1 Genea Limited Company Details
  13.2.2 Genea Limited Business Overview and Its Total Revenue
  13.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.2.5 Genea Limited Recent Development
13.3 Quest Diagnostics
  13.3.1 Quest Diagnostics Company Details
  13.3.2 Quest Diagnostics Business Overview and Its Total Revenue
  13.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.3.5 Quest Diagnostics Recent Development
13.4 Illumina, Inc.
  13.4.1 Illumina, Inc. Company Details
  13.4.2 Illumina, Inc. Business Overview and Its Total Revenue
  13.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.4.5 Illumina, Inc. Recent Development
13.5 Natera, Inc.
  13.5.1 Natera, Inc. Company Details
  13.5.2 Natera, Inc. Business Overview and Its Total Revenue
  13.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.5.5 Natera, Inc. Recent Development
13.6 Cooper Medical, Inc.
  13.6.1 Cooper Medical, Inc. Company Details
  13.6.2 Cooper Medical, Inc. Business Overview and Its Total Revenue
  13.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.6.5 Cooper Medical, Inc. Recent Development
13.7 LabCorp
  13.7.1 LabCorp Company Details
  13.7.2 LabCorp Business Overview and Its Total Revenue
  13.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.7.5 LabCorp Recent Development
13.8 California Pacific Medical Center (CPMC)
  13.8.1 California Pacific Medical Center (CPMC) Company Details
  13.8.2 California Pacific Medical Center (CPMC) Business Overview and Its Total Revenue
  13.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.8.5 California Pacific Medical Center (CPMC) Recent Development
13.9 Thermo Fisher Scientific Inc.
  13.9.1 Thermo Fisher Scientific Inc. Company Details
  13.9.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  13.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.9.5 Thermo Fisher Scientific Inc. Recent Development
13.10 IGENOMIX
  13.10.1 IGENOMIX Company Details
  13.10.2 IGENOMIX Business Overview and Its Total Revenue
  13.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
  13.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  13.10.5 IGENOMIX Recent Development
13.11 Reproductive Genetic Innovations
  10.11.1 Reproductive Genetic Innovations Company Details
  10.11.2 Reproductive Genetic Innovations Business Overview and Its Total Revenue
  10.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
  10.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  10.11.5 Reproductive Genetic Innovations Recent Development
13.12 CombiMatrix
  10.12.1 CombiMatrix Company Details
  10.12.2 CombiMatrix Business Overview and Its Total Revenue
  10.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
  10.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
  10.12.5 CombiMatrix Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pre-Implantation Genetic Diagnosis (PGD) Key Market Segments
Table 2. Key Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
Table 3. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chromosomal Abnormalities
Table 6. Key Players of X-linked Diseases
Table 7. Key Players of Freeze Embryo Testing
Table 8. Key Players of Aneuploidy Screening
Table 9. Key Players of HLA
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Pre-Implantation Genetic Diagnosis (PGD) Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Pre-Implantation Genetic Diagnosis (PGD) Players to Combat Covid-19 Impact
Table 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2015-2020)
Table 20. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Pre-Implantation Genetic Diagnosis (PGD) Market Growth Strategy
Table 26. Main Points Interviewed from Key Pre-Implantation Genetic Diagnosis (PGD) Players
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2015-2020) (Million US$)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2015-2020)
Table 29. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2019)
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
Table 33. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Type (2015-2020)
Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2021-2026)
Table 38. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2015-2020)
Table 39. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 40. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2021-2026)
Table 41. North America Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 43. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 44. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 45. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 46. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 47. Europe Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 49. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 51. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 53. China Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 54. China Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 55. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 56. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 57. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 58. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 59. Japan Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 61. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 63. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 67. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 69. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 71. India Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 72. India Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 73. India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 74. India Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 75. India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 76. India Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Pre-Implantation Genetic Diagnosis (PGD) Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Pre-Implantation Genetic Diagnosis (PGD) Market Share (2019-2020)
Table 79. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2015-2020)
Table 81. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2015-2020)
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Product
Table 86. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 87. Roche Recent Development
Table 88. Genea Limited Company Details
Table 89. Genea Limited Business Overview
Table 90. Genea Limited Product
Table 91. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 92. Genea Limited Recent Development
Table 93. Quest Diagnostics Company Details
Table 94. Quest Diagnostics Business Overview
Table 95. Quest Diagnostics Product
Table 96. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 97. Quest Diagnostics Recent Development
Table 98. Illumina, Inc. Company Details
Table 99. Illumina, Inc. Business Overview
Table 100. Illumina, Inc. Product
Table 101. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 102. Illumina, Inc. Recent Development
Table 103. Natera, Inc. Company Details
Table 104. Natera, Inc. Business Overview
Table 105. Natera, Inc. Product
Table 106. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 107. Natera, Inc. Recent Development
Table 108. Cooper Medical, Inc. Company Details
Table 109. Cooper Medical, Inc. Business Overview
Table 110. Cooper Medical, Inc. Product
Table 111. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 112. Cooper Medical, Inc. Recent Development
Table 113. LabCorp Company Details
Table 114. LabCorp Business Overview
Table 115. LabCorp Product
Table 116. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 117. LabCorp Recent Development
Table 118. California Pacific Medical Center (CPMC) Business Overview
Table 119. California Pacific Medical Center (CPMC) Product
Table 120. California Pacific Medical Center (CPMC) Company Details
Table 121. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 122. California Pacific Medical Center (CPMC) Recent Development
Table 123. Thermo Fisher Scientific Inc. Company Details
Table 124. Thermo Fisher Scientific Inc. Business Overview
Table 125. Thermo Fisher Scientific Inc. Product
Table 126. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 127. Thermo Fisher Scientific Inc. Recent Development
Table 128. IGENOMIX Company Details
Table 129. IGENOMIX Business Overview
Table 130. IGENOMIX Product
Table 131. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 132. IGENOMIX Recent Development
Table 133. Reproductive Genetic Innovations Company Details
Table 134. Reproductive Genetic Innovations Business Overview
Table 135. Reproductive Genetic Innovations Product
Table 136. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 137. Reproductive Genetic Innovations Recent Development
Table 138. CombiMatrix Company Details
Table 139. CombiMatrix Business Overview
Table 140. CombiMatrix Product
Table 141. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) (Million US$)
Table 142. CombiMatrix Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2026
Figure 2. Chromosomal Abnormalities Features
Figure 3. X-linked Diseases Features
Figure 4. Freeze Embryo Testing Features
Figure 5. Aneuploidy Screening Features
Figure 6. HLA Features
Figure 7. Others Features
Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026
Figure 9. Stem Cell Therapy Case Studies
Figure 10. IVF Prognosis Case Studies
Figure 11. Late-Onset Genetic Disorders Case Studies
Figure 12. Inherited Genetic Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2026
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2019
Figure 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2019
Figure 22. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 31. Genea Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 33. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 35. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 37. Natera, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 39. Cooper Medical, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 41. LabCorp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 43. California Pacific Medical Center (CPMC) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 45. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 47. IGENOMIX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 49. Reproductive Genetic Innovations Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 51. CombiMatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed